These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12887167)

  • 1. The prevalence of GP Mur and anti-"Mia" in a tertiary hospital in Peninsula Malaysia.
    Prathiba R; Lopez CG; Usin FM
    Malays J Pathol; 2002 Dec; 24(2):95-8. PubMed ID: 12887167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful prenatal management of two foetuses affected by antibodies against GP.Mur with prenatal genotyping analysis and a literature review.
    Li S; Wei L; Fang Q; Ji Y; Lin L; Gao Y
    Blood Transfus; 2021 Mar; 19(2):135-143. PubMed ID: 33085590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The distribution of the MiIII (Gp.Mur) phenotype among the population of Taiwan.
    Broadberry RE; Lin M
    Transfus Med; 1996 Jun; 6(2):145-8. PubMed ID: 8809963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolytic disease of the fetus and newborn caused by anti-s
    Lopez GH; Emthip M; Suwanwootichai P; Millard GM; Wilson B; Onpuns S; Laemsri K; Chiewsilp P; Flower RL; Hyland CA; Liew YW
    Transfusion; 2022 Oct; 62(10):2137-2142. PubMed ID: 36062546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of GP. Mur antigen-negative RBC for blood recipients with anti-'Mi
    Yang CA; Lin JA; Chang CW; Wu KH; Yeh SP; Ho CM; Chang JG
    Transfus Med; 2016 Oct; 26(5):349-354. PubMed ID: 27634577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The distribution of MNS hybrid glycophorins with Mur antigen expression in Chinese donors including identification of a novel GYP.Bun allele.
    Wei L; Shan ZG; Flower RL; Wang Z; Wen JZ; Luo GP; Ji YL
    Vox Sang; 2016 Oct; 111(3):308-314. PubMed ID: 27232276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey of the incidence of Miltenberger antibodies among Hong Kong Chinese blood donors.
    Mak KH; Banks JA; Lubenko A; Chua KM; Torres de Jardine AL; Yan KF
    Transfusion; 1994 Mar; 34(3):238-41. PubMed ID: 8146897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetic analysis of Mi
    Wei L; Sun A; Wen J; Wang Z; Li Q; Liao Y; Luo G; Ji Y
    Transfusion; 2021 Aug; 61(8):2477-2486. PubMed ID: 34117642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and specificity of red-blood-cell antibodies in a multiethnic South and East Asian patient population and influence of using novel MUT+Mur+ kodecytes on its detection.
    Nadarajan VS; Laing AA; Saad SM; Usin M
    Vox Sang; 2012 Jan; 102(1):65-71. PubMed ID: 21592136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence and significance of anti-"Mia" in Taiwan.
    Broadberry RE; Lin M
    Transfusion; 1994 Apr; 34(4):349-52. PubMed ID: 8178333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrops foetalis caused by anti-Mur in first pregnancy--a case report.
    Wu KH; Chang JG; Lin M; Shih MC; Lin H; Lee CC; Peng CT; Tsai CH
    Transfus Med; 2002 Oct; 12(5):325-7. PubMed ID: 12383339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A direct blood polymerase chain reaction approach for the determination of GP.Mur (Mi.III) and other Hil+ Miltenberger glycophorin variants.
    Hsu K; Lin YC; Chang YC; Chan YS; Chao HP; Lee TY; Lin M
    Transfusion; 2013 May; 53(5):962-71. PubMed ID: 22924868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First case of haemolytic disease of the newborn due to anti-Mur in Hong Kong.
    Lin CK; Mak KH; Szeto SC; Poon KH; Yuen CM; Chan NK; Liu HW; Ng CP
    Clin Lab Haematol; 1996 Mar; 18(1):19-22. PubMed ID: 9118598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of GP. Mur variant phenotype among Malaysian blood donors.
    Hassan SN; Mohamad S; Kannan TP; Hassan R; Wei S; Wan Ab Rahman WS
    Asian J Transfus Sci; 2023; 17(2):169-174. PubMed ID: 38274953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Universal Detection of Mi
    Yang MH; Chen JW; Sayaka K; Uchikawa M; Tsuno NH; Wei ST; Hou SM; Chen YJ
    Diagnostics (Basel); 2021 Apr; 11(5):. PubMed ID: 33946749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of GYP(B-A-B) hybrid glycophorins among Thai blood donors with Mi
    Nathalang O; Khumsuk P; Chaibangyang W; Intharanut K
    Blood Transfus; 2024 May; 22(3):198-205. PubMed ID: 38063789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mur (MNS 10) screening with a novel loop-mediated isothermal amplification assay in Zhongshan, China.
    Wei SS; Sun AN; Ding SH; Meng QL; Wang HM; Duan SB; Tian JJ; Chen YZ; Liu XM; Li Y; Liao YT
    Transfus Med; 2016 Jun; 26(3):215-9. PubMed ID: 27102363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on the antigens and antibodies of Mur and Mi
    Li Q; Duan S; Sun A; Liao Y; Wu Y; Wang H; Lin H; Huang X; Zhan Z
    Transfus Apher Sci; 2022 Aug; 61(4):103378. PubMed ID: 35216928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of hydrops fetalis, probably due to antibodies directed against antigenic determinants of GP.Mur (Miltenberger class III) cells.
    Lin CK; Mak KH; Yuen CM; Chan NK; Liu HW; Cheng G
    Immunohematology; 1996; 12(3):115-8. PubMed ID: 15387736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case report on anti-Mia antibody in a multi-transfused patient from India.
    Agrawal S; Chowdhry M
    Transfus Apher Sci; 2019 Oct; 58(5):625-627. PubMed ID: 31515172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.